Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Blockade of crizotinib-induced BCL2 elevation in ALK-positive anaplastic large cell lymphoma triggers autophagy associated with cell death.
Haematologica. 2019 Jul;104(7):1428-1439. doi: 10.3324/haematol.2017.181966. Epub 2019 Jan 24.
Haematologica. 2019.
PMID: 30679328
Free PMC article.
Gene Expression Signature Associated with Clinical Outcome in ALK-Positive Anaplastic Large Cell Lymphoma.
Daugrois C, Bessiere C, Dejean S, Anton-Leberre V, Commes T, Pyronnet S, Brousset P, Espinos E, Brugiere L, Meggetto F, Lamant L.
Daugrois C, et al.
Cancers (Basel). 2021 Nov 3;13(21):5523. doi: 10.3390/cancers13215523.
Cancers (Basel). 2021.
PMID: 34771686
Free PMC article.
Item in Clipboard
Reversal of microRNA-150 silencing disadvantages crizotinib-resistant NPM-ALK(+) cell growth.
Hoareau-Aveilla C, Valentin T, Daugrois C, Quelen C, Mitou G, Quentin S, Jia J, Spicuglia S, Ferrier P, Ceccon M, Giuriato S, Gambacorti-Passerini C, Brousset P, Lamant L, Meggetto F.
Hoareau-Aveilla C, et al. Among authors: daugrois c.
J Clin Invest. 2015 Sep;125(9):3505-18. doi: 10.1172/JCI78488. Epub 2015 Aug 10.
J Clin Invest. 2015.
PMID: 26258416
Free PMC article.
Item in Clipboard
Doxorubicin-induced loss of DNA topoisomerase II and DNMT1- dependent suppression of MiR-125b induces chemoresistance in ALK-positive cells.
Congras A, Caillet N, Torossian N, Quelen C, Daugrois C, Brousset P, Lamant L, Meggetto F, Hoareau-Aveilla C.
Congras A, et al. Among authors: daugrois c.
Oncotarget. 2018 Feb 8;9(18):14539-14551. doi: 10.18632/oncotarget.24465. eCollection 2018 Mar 6.
Oncotarget. 2018.
PMID: 29581862
Free PMC article.
Item in Clipboard
Recombinant human IL-15 trans-presentation by B leukemic cells from chronic lymphocytic leukemia induces autologous NK cell proliferation leading to improved anti-CD20 immunotherapy.
Laprevotte E, Voisin G, Ysebaert L, Klein C, Daugrois C, Laurent G, Fournie JJ, Quillet-Mary A.
Laprevotte E, et al. Among authors: daugrois c.
J Immunol. 2013 Oct 1;191(7):3634-40. doi: 10.4049/jimmunol.1300187. Epub 2013 Aug 30.
J Immunol. 2013.
PMID: 23997218
Item in Clipboard
Cite
Cite